Masong, Harmelene C.
HRN: 10-67-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/30/2022
OXACILLIN 500MG (VIAL)
09/30/2022
10/07/2022
IV
575mg
Q6Hrs
Tc Fungal Infection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes